Sildenafil therapy for neonatal and childhood pulmonary hypertensive vascular disease.
(2011) Cardiology in the Young — Vol. 21, n° 2, p. 187-193 (2011)
Files
No attached file found for this publication.
Details
- Authors
- Abstract
- In children under 5 years of age with severe pulmonary hypertension, sildenafil therapy resulted in prolonged hemodynamic improvements without adverse effects. Sildenafil attenuated rebound pulmonary hypertension after withdrawal of inhaled nitric oxide.
- Affiliations
Citations
Humpl, T., Reyes, J. T., Erickson, S., Armano, R., Holtby, H., & Adatia, I. (2011). Sildenafil therapy for neonatal and childhood pulmonary hypertensive vascular disease. Cardiology in the Young, 21(2), 187-193. https://doi.org/10.1017/S1047951110001745 (Original work published 2011)